Tirzepatide 500mcg Tablets | 25-Count

$230.00

Tirzepatide (Dual GIP/GLP-1 Receptor Agonist) — ≥99% HPLC purity, MS confirmed, Janoshik COA. 500mcg per tablet, 25-count. Research use only.

Category:

Description

What is Tirzepatide?

Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist — the first in its class of “twincretins.” Acts simultaneously on GIPR and GLP-1R to produce synergistic effects on insulin secretion, glucagon suppression, gastric emptying delay, and appetite suppression. Oral tablet formulation for GIP/GLP-1 pathway research without injection. Research use only.

Reviews

There are no reviews yet.

Be the first to review “Tirzepatide 500mcg Tablets | 25-Count”

Your email address will not be published. Required fields are marked *

Add to cart